Healthcare Industry
-
Embla Medical hf: Q4 and Full Year 2025 Interim Report
Embla Medical announced its Q4 and full-year 2025 financial results, highlighting strong revenue growth driven by international product adoption. The company focused on R&D for next-generation AI-powered devices and expanded its intellectual property portfolio. Investments were made to optimize the supply chain and manufacturing for resilience. Embla Medical is optimistic about future growth, with a robust pipeline and strategic partnerships planned to advance healthcare technology.